Key players in the European Ophthalmology Surgery Devices Market are Allergan, Inc., Abbott Laboratories, BAUSCH & LOMB, Inc., Alcon, Valeant Pharmaceuticals International, Inc. & others.
(PRWEB) September 22, 2014
The European ophthalmology surgery devices market report defines and segments the concerned market in Europe with analysis and forecast of revenue. The market in Europe was valued $1,321.9 million in 2012 and is estimated to grow at a CAGR of 4.4% from 2013 to 2018.
Browse through the TOC of the European ophthalmology surgery devices market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of the market in the same region, and is supported by various tables and figures.
Europe is the second-largest market for ophthalmology surgery devices, globally. This is due to the rapidly aging population and rising governmental expenditure on healthcare across the region. The region is expected to witness growth at a slower pace due to the impacts of the Euro zone crisis in 2009 especially in countries, such as Italy and Spain. Germany has contributed the largest share in the European ophthalmology surgery devices market, with a share of around 25.1% in 2013.
Speak to Analyst @
The rising cataract procedures will increase the demand for ophthalmology surgery devices. The year 2012 witnessed an increase of 2% in the cataract surgeries in Europe. The incidence rates of various eye diseases are also on the rise, which is due to the rapidly aging population. Moreover, the overall prevalence rate for age related macular degeneration (AMD) in 2012 in the U.K. was found to be 2.4% in the population, particularly within the age group of 50 and above. In 2012, the rate of prevalence percentage increased the number of cataract cases as high as 500 thousand cases, which is estimated to increase the cases to 700 thousand by 2020. This increase in the number of cases will raise the number of cataract surgery procedures and thereby, drive the ophthalmology surgery devices market.
Early buyers will receive 10% customization on this report.
Higher prevalence of obesity and diabetes in the region is also a cause of rising ophthalmic disorders, leading to blindness. The obesity rates in the region has been rising since last 20 years and leading to diabetes.
The reimbursement policies of Europe are similar to that in the U.S. Europe has a policy of 100% reimbursement for the use of standard IOLs during cataract surgeries. Some reimbursement policies of the European countries favor the use of premium lenses during cataract surgeries, such as Portugal.
The major companies extensively covered in this report are Alcon-Novartis (Switzerland) that possesses a lion’s share in the market, followed by Abbott Medical Optics Inc. (U.S.), Bausch & Lomb (U.S.), Allergan, Inc. (U.S.), and others.
The report on the European ophthalmology surgery devices market analyzes the devices under four segments; cataract, glaucoma, refractive, and vitreoretinal surgery. The market is further segmented and forecast on the basis of major countries, such as the Germany, France, Italy, the U.K., and Spain. The market is also segmented and analyzed further on the basis of the end-users of the devices mainly hospitals, private eye clinics, and other end-users.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities. In addition, it presents a competitive landscape and company profiles of the key players in the market.
North American Ophthalmology Surgery Devices Market
Opthalmology Surgery Devices-North America market has been pegged at 1,936.1 m in the year 2013 growing at 4.4% annually and is projected to reach 2,404.4 m by the end of the year 2018. Opthalmology Surgery Devices-North America constitute 36.8% of Global Ophthalmology Surgery Devices market and are poised to grow its market share to 32.6% by the end of year 2018.Peers of Hydrocolloids are Cataract Surgery Devices, Refractive Surgery Devices, Vitreoretinal Surgery Devices and Glaucoma Surgery Devices comprising 79.6%, 9.0%, 8.7% and 2.8% respectively of the Global Ophthalmology Surgery Devices market.It is segmented on basis of endusers and geographies.
Asian Ophthalmology Surgery Devices Market
Opthalmology Surgery Devices-Asia market has been pegged at 1,221.5 m in the year 2013 growing at 11.6% annually and is projected to reach 2,110.9 m by the end of the year 2018. Opthalmology Surgery Devices-Asia constitute 23.2% of Global Ophthalmology Surgery Devices market and are poised to grow its market share to 28.6% by the end of year 2018.Peers of Hydrocolloids are Cataract Surgery Devices, Refractive Surgery Devices, Vitreoretinal Surgery Devices and Glaucoma Surgery Devices comprising 79.6%, 9.0%, 8.7% and 2.8% respectively of the Global Ophthalmology Surgery Devices market.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.